title: Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit.
abstract: We examined whether coupling of a ventricular myocyte to a non-myocyte cell expressing HCN2 could create a two-cell syncytium capable of generating sustained pacing. Three non-myocyte cell types were transfected with the mHCN2 gene and used as sources of mHCN2-induced currents. They were human mesenchymal stem cells and HEK293 cells, both of which express connexin43 (Cx43), and HeLa cells transfected with Cx43. Cell-cell coupling between heterologous pairs increased with time in co-culture, and hyperpolarization of the myocyte induced HCN2 currents, indicating current transfer from the mHCN2-expressing cell to the myocyte via gap junctions. The magnitude of the HCN2 currents recorded in myocytes increased with increasing junctional conductance. Once a critical level of electrical cell-cell coupling between myocytes and mHCN2 transfected cells was exceeded spontaneous action potentials were generated at frequencies of approximately 0.6 to 1.7 Hz (1.09 +/- 0.05 Hz). Addition of carbenoxolone (200 microM), a gap junction channel blocker, to the media stopped spontaneous activity in heterologous cell pairs. Carbenoxolone washout restored activity. Blockade of HCN2 currents by 100 microM 9-amino-1,2,3,4-tetrahydroacridine (THA) stopped spontaneous activity and subsequent washout restored it. Neither THA nor carbenoxolone affected electrically stimulated action potentials in isolated single myocytes. In summary, the inward current evoked in the genetically engineered (HCN2-expressing) cell was delivered to the cardiac myocyte via gap junctions and generated action potentials such that the cell pair could function as a pacemaker unit. This finding lays the groundwork for understanding cell-based biological pacemakers in vivo once an understanding of delivery and target cell geometry is defined.
authors.affiliation: Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794-8661, USA.
authors.forename: V
authors.initials: V
authors.lastname: Valiunas
authors.forename: G
authors.initials: G
authors.lastname: Kanaporis
authors.forename: L
authors.initials: L
authors.lastname: Valiuniene
authors.forename: C
authors.initials: C
authors.lastname: Gordon
authors.forename: H Z
authors.initials: HZ
authors.lastname: Wang
authors.forename: L
authors.initials: L
authors.lastname: Li
authors.forename: R B
authors.initials: RB
authors.lastname: Robinson
authors.forename: M R
authors.initials: MR
authors.lastname: Rosen
authors.forename: I S
authors.initials: IS
authors.lastname: Cohen
authors.forename: P R
authors.initials: PR
authors.lastname: Brink
mesh_terms: D000200:Action Potentials / Q000502:physiology*; D000818:Animals; D001683:Biological Clocks / Q000502:physiology*; D002450:Cell Communication / Q000502:physiology*; D002478:Cells, Cultured; D004285:Dogs; D025461:Feedback, Physiological / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; D007473:Ion Channels / Q000378:metabolism*; D007668:Kidney / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000502:physiology*; D015221:Potassium Channels
chemical_list: C578710:HCN2 protein, human; D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; D007473:Ion Channels; D015221:Potassium Channels